AP2016009002A0 - Use of a combination of an inhibitor of the if current of the sinus node and an inhibitor of the angiotensin converting enzyme for the treatment of heart failure - Google Patents

Use of a combination of an inhibitor of the if current of the sinus node and an inhibitor of the angiotensin converting enzyme for the treatment of heart failure

Info

Publication number: AP2016009002A0
Authority: AP; ARIPO
Prior art keywords: inhibitor; treatment; combination; current; heart failure
Prior art date: 2010-06-15

Application number

AP2016009002A

Other languages

English (en)

Inventor

Jerome Roussel

Luc Feldmann

Guy Lerebours-Pigeonniere

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-06-15

Filing date

2011-06-14

Publication date

2016-01-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42985210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2016009002(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-06-14 Application filed by Servier Lab filed Critical Servier Lab

2016-01-31 Publication of AP2016009002A0 publication Critical patent/AP2016009002A0/xx

Links

239000003112 inhibitor Substances 0.000 title 2
UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 title 1
206010019280 Heart failures Diseases 0.000 title 1
102000004270 Peptidyl-Dipeptidase A Human genes 0.000 title 1
108090000882 Peptidyl-Dipeptidase A Proteins 0.000 title 1
210000001013 sinoatrial node Anatomy 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Peptides Or Proteins (AREA)
Plural Heterocyclic Compounds (AREA)
Display Devices Of Pinball Game Machines (AREA)

AP2016009002A 2010-06-15 2011-06-14 Use of a combination of an inhibitor of the if current of the sinus node and an inhibitor of the angiotensin converting enzyme for the treatment of heart failure AP2016009002A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR1002525A FR2961105B1 (fr)	2010-06-15	2010-06-15	Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
PCT/FR2011/000345 WO2011157908A1 (fr)	2010-06-15	2011-06-14	Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque

Publications (1)

Publication Number	Publication Date
AP2016009002A0 true AP2016009002A0 (en)	2016-01-31

Family

ID=42985210

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AP2016009002A AP2016009002A0 (en)	2010-06-15	2011-06-14	Use of a combination of an inhibitor of the if current of the sinus node and an inhibitor of the angiotensin converting enzyme for the treatment of heart failure
AP2013006661A AP3691A (en)	2010-06-15	2011-06-14	Use of the combination of an inhibitor of the if current of the sinoatrial node and an inhibitor of the angiotensin-converting enzyme for treating heart failure

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AP2013006661A AP3691A (en)	2010-06-15	2011-06-14	Use of the combination of an inhibitor of the if current of the sinoatrial node and an inhibitor of the angiotensin-converting enzyme for treating heart failure

Country Status (48)

Country	Link
US (1)	US20110306598A1 (pt)
EP (2)	EP2404600B1 (pt)
JP (1)	JP5480202B2 (pt)
KR (1)	KR101389879B1 (pt)
CN (2)	CN102284060A (pt)
AP (2)	AP2016009002A0 (pt)
AR (1)	AR081875A1 (pt)
AU (1)	AU2011202607B2 (pt)
BR (1)	BRPI1102830F1 (pt)
CA (1)	CA2743527C (pt)
CL (1)	CL2011001420A1 (pt)
CO (1)	CO6640265A2 (pt)
CR (1)	CR20120609U (pt)
CU (1)	CU24161B1 (pt)
CY (2)	CY1116438T1 (pt)
DK (2)	DK2921168T3 (pt)
EA (1)	EA022612B1 (pt)
EC (1)	ECSP12012337A (pt)
ES (2)	ES2582157T3 (pt)
FR (1)	FR2961105B1 (pt)
GE (1)	GEP20146132B (pt)
GT (1)	GT201200341A (pt)
HK (1)	HK1210012A1 (pt)
HR (2)	HRP20150745T1 (pt)
HU (2)	HUE027088T2 (pt)
IL (1)	IL223293A (pt)
JO (1)	JO3309B1 (pt)
MA (1)	MA33235B1 (pt)
ME (2)	ME02163B (pt)
MX (1)	MX2011006001A (pt)
MY (1)	MY179034A (pt)
NI (1)	NI201200182A (pt)
NZ (2)	NZ593437A (pt)
PE (1)	PE20120019A1 (pt)
PH (1)	PH12012502315B1 (pt)
PL (2)	PL2404600T3 (pt)
PT (1)	PT2404600E (pt)
PY (1)	PY1124031A (pt)
RS (2)	RS54077B1 (pt)
SA (2)	SA111320527B1 (pt)
SG (2)	SG177069A1 (pt)
SI (2)	SI2404600T1 (pt)
TN (1)	TN2012000551A1 (pt)
TW (1)	TWI468164B (pt)
UA (1)	UA108983C2 (pt)
UY (1)	UY33423A (pt)
WO (1)	WO2011157908A1 (pt)
ZA (1)	ZA201104222B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102603666A (zh) *	2012-02-28	2012-07-25	石河子大学	肉桂酰牛磺酰噻唑烷酸类化合物及其应用
FR3020810B1 (fr) *	2014-05-06	2016-05-06	Servier Lab	Nouveau sel de l'ivabradine et son procede de preparation.
EP3025705B8 (en) *	2014-11-25	2018-11-28	Sanofi Ilaç Sanayi ve Ticaret Anonim Sirketi	Stable ivabradine formulations
PH12018502155B1 (en)	2016-04-20	2024-03-27	Servier Lab	Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
KR20190001340A (ko) *	2017-06-27	2019-01-04	에리슨제약(주)	이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법
CN107714702A (zh) *	2017-10-31	2018-02-23	泰州中国医药城中医药研究院	一种伊伐布雷定和米力农组合物及其在制药中的应用
CN107550915A (zh) *	2017-10-31	2018-01-09	泰州中国医药城中医药研究院	一种伊伐布雷定和咯利普兰组合物及其在制药中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2681862B1 (fr)	1991-09-27	1993-11-12	Adir Cie	Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
US6188743B1 (en) *	1997-10-10	2001-02-13	Analogic Corporation	Computed tomography scanner drive system and bearing
FR2807431B1 (fr) *	2000-04-06	2002-07-19	Adir	Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
DE10018401A1 (de) *	2000-04-13	2001-10-25	Boehringer Ingelheim Pharma	Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
FR2838648B1 (fr)	2002-04-18	2004-05-21	Servier Lab	Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
EP1362590B1 (en) *	2002-07-25	2004-01-07	Boehringer Ingelheim Pharma GmbH & Co.KG	Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
ES2384637T3 (es) *	2004-10-08	2012-07-10	Novartis Ag	Uso de inhibidores de la renina para la prevención o el tratamiento de disfunción diastólica o insuficiencia cardiaca diastólica
WO2007014051A2 (en) *	2005-07-22	2007-02-01	Amylin Pharmaceuticals, Inc.	Use of amylin and amylin agonists as cardioprotective or myoprotective agents
FR2891826B1 (fr) *	2005-10-11	2007-12-28	Servier Lab	Forme cristalline 6 du chlorhydrate de l'ivabradine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2894825B1 (fr) *	2005-12-21	2010-12-03	Servier Lab	Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2911279B1 (fr) *	2007-01-11	2009-03-06	Servier Lab	Utilisation de l'ivabradine pour l'obtention de medicaments destines au traitement de la dysfonction endotheliale
FR2920773B1 (fr) *	2007-09-11	2009-10-23	Servier Lab	Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2921365B1 (fr)	2007-09-21	2012-10-12	Servier Lab	Nouveaux sels d'addition d'inhibiteurs d'enzyme de conversion de l'angiotensine a des acides donneurs de no, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2927538B1 (fr) *	2008-02-14	2010-02-19	Servier Lab	Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
RU2364401C1 (ru) *	2008-05-12	2009-08-20	Государственное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия имени академика Е.А. Вагнера Федерального агентства по здравоохранению и социальному развитию"	Способ коррекции сосудистого ремоделирования у больных хронической сердечной недостаточностью ишемической этиологии
WO2009158005A1 (en) *	2008-06-27	2009-12-30	Concert Pharmaceuticals, Inc.	Benzazepinone compounds
RU2382644C1 (ru)	2008-11-05	2010-02-27	Государственное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия имени академика Е.А. Вагнера Федерального агентства по здравоохранению и социальному развитию"	Способ коррекции гипертрофии левого желудочка у больных ибс в сочетании с гипертонической болезнью

2010
- 2010-06-15 FR FR1002525A patent/FR2961105B1/fr not_active Expired - Fee Related
2011
- 2011-05-31 PE PE2011001126A patent/PE20120019A1/es not_active Application Discontinuation
- 2011-05-31 SG SG2011039419A patent/SG177069A1/en unknown
- 2011-05-31 AU AU2011202607A patent/AU2011202607B2/en not_active Ceased
- 2011-05-31 SG SG10201500502WA patent/SG10201500502WA/en unknown
- 2011-05-31 JO JOP/2011/0178A patent/JO3309B1/ar active
- 2011-06-01 MY MYPI2011002498A patent/MY179034A/en unknown
- 2011-06-02 UY UY0001033423A patent/UY33423A/es not_active Application Discontinuation
- 2011-06-07 MX MX2011006001A patent/MX2011006001A/es active IP Right Grant
- 2011-06-07 ZA ZA2011/04222A patent/ZA201104222B/en unknown
- 2011-06-08 MA MA33924A patent/MA33235B1/fr unknown
- 2011-06-09 TW TW100120215A patent/TWI468164B/zh not_active IP Right Cessation
- 2011-06-10 CA CA2743527A patent/CA2743527C/fr not_active Expired - Fee Related
- 2011-06-10 GE GEAP201112259A patent/GEP20146132B/en unknown
- 2011-06-10 CL CL2011001420A patent/CL2011001420A1/es unknown
- 2011-06-13 NZ NZ593437A patent/NZ593437A/xx not_active IP Right Cessation
- 2011-06-13 SA SA111320527A patent/SA111320527B1/ar unknown
- 2011-06-13 AR ARP110102044A patent/AR081875A1/es unknown
- 2011-06-13 NZ NZ600931A patent/NZ600931A/xx not_active IP Right Cessation
- 2011-06-13 SA SA114360089A patent/SA114360089B1/ar unknown
- 2011-06-14 ME MEP-2015-95A patent/ME02163B/me unknown
- 2011-06-14 PT PT112902697T patent/PT2404600E/pt unknown
- 2011-06-14 WO PCT/FR2011/000345 patent/WO2011157908A1/fr not_active Ceased
- 2011-06-14 RS RS20150435A patent/RS54077B1/sr unknown
- 2011-06-14 DK DK15162899.7T patent/DK2921168T3/en active
- 2011-06-14 RS RS20160422A patent/RS54838B1/sr unknown
- 2011-06-14 EP EP11290269.7A patent/EP2404600B1/fr not_active Revoked
- 2011-06-14 EA EA201100773A patent/EA022612B1/ru unknown
- 2011-06-14 PY PY201101124031A patent/PY1124031A/es unknown
- 2011-06-14 HU HUE11290269A patent/HUE027088T2/en unknown
- 2011-06-14 PL PL11290269T patent/PL2404600T3/pl unknown
- 2011-06-14 UA UAA201107469A patent/UA108983C2/en unknown
- 2011-06-14 EP EP15162899.7A patent/EP2921168B1/fr active Active
- 2011-06-14 SI SI201130568T patent/SI2404600T1/sl unknown
- 2011-06-14 CU CU20120166A patent/CU24161B1/es active IP Right Grant
- 2011-06-14 AP AP2016009002A patent/AP2016009002A0/xx unknown
- 2011-06-14 ME MEP-2016-90A patent/ME02476B/me unknown
- 2011-06-14 ES ES15162899.7T patent/ES2582157T3/es active Active
- 2011-06-14 PL PL15162899.7T patent/PL2921168T3/pl unknown
- 2011-06-14 BR BRPI1102830A patent/BRPI1102830F1/pt not_active IP Right Cessation
- 2011-06-14 PH PH1/2012/502315A patent/PH12012502315B1/en unknown
- 2011-06-14 US US13/134,667 patent/US20110306598A1/en not_active Abandoned
- 2011-06-14 DK DK11290269.7T patent/DK2404600T3/en active
- 2011-06-14 HU HUE15162899A patent/HUE027788T2/en unknown
- 2011-06-14 AP AP2013006661A patent/AP3691A/xx active
- 2011-06-14 ES ES11290269.7T patent/ES2545343T3/es active Active
- 2011-06-14 SI SI201130879A patent/SI2921168T1/sl unknown
- 2011-06-14 KR KR1020110057585A patent/KR101389879B1/ko not_active Expired - Fee Related
- 2011-06-15 JP JP2011132849A patent/JP5480202B2/ja active Active
- 2011-06-15 CN CN2011101600748A patent/CN102284060A/zh active Pending
- 2011-06-15 CN CN201510337337.6A patent/CN104906579A/zh active Pending
2012
- 2012-11-23 TN TNP2012000551A patent/TN2012000551A1/fr unknown
- 2012-11-27 IL IL223293A patent/IL223293A/en active IP Right Grant
- 2012-12-03 CR CR20120609U patent/CR20120609U/es unknown
- 2012-12-07 NI NI201200182A patent/NI201200182A/es unknown
- 2012-12-10 CO CO12223070A patent/CO6640265A2/es not_active Application Discontinuation
- 2012-12-14 EC ECSP12012337 patent/ECSP12012337A/es unknown
- 2012-12-14 GT GT201200341A patent/GT201200341A/es unknown
2015
- 2015-06-08 CY CY20151100503T patent/CY1116438T1/el unknown
- 2015-07-08 HR HRP20150745TT patent/HRP20150745T1/hr unknown
- 2015-10-28 HK HK15110661.0A patent/HK1210012A1/xx unknown
2016
- 2016-06-09 HR HRP20160643TT patent/HRP20160643T1/hr unknown
- 2016-06-10 CY CY20161100508T patent/CY1117724T1/el unknown

Also Published As

Publication number	Publication date
BRPI1102830A2 (pt)	2013-12-24
CN102284060A (zh)	2011-12-21
CL2011001420A1 (es)	2012-07-06
SA111320527B1 (ar)	2015-03-19
JO3309B1 (ar)	2018-09-16
DK2921168T3 (en)	2016-08-01
SI2921168T1 (sl)	2016-08-31
NZ600931A (en)	2013-04-26
SG10201500502WA (en)	2015-03-30
CA2743527C (fr)	2016-08-02
PY1124031A (es)	2014-10-01
MX2011006001A (es)	2011-12-14
NZ593437A (en)	2012-08-31
AP3691A (en)	2016-04-30
AR081875A1 (es)	2012-10-24
HK1210012A1 (en)	2016-04-15
SG177069A1 (en)	2012-01-30
TN2012000551A1 (fr)	2014-04-01
CO6640265A2 (es)	2013-03-22
NI201200182A (es)	2013-05-13
TWI468164B (zh)	2015-01-11
JP5480202B2 (ja)	2014-04-23
ES2545343T3 (es)	2015-09-10
PT2404600E (pt)	2015-07-13
ZA201104222B (en)	2012-02-29
AP2013006661A0 (en)	2013-01-31
UA108983C2 (en)	2015-07-10
AU2011202607A1 (en)	2012-01-12
SI2404600T1 (sl)	2015-10-30
BRPI1102830B8 (pt)	2020-01-07
EA022612B1 (ru)	2016-02-29
MY179034A (en)	2020-10-26
HUE027088T2 (en)	2016-08-29
EP2921168A1 (fr)	2015-09-23
UY33423A (es)	2011-12-30
EP2921168B1 (fr)	2016-04-13
BRPI1102830B1 (pt)	2019-10-08
PL2404600T3 (pl)	2015-10-30
WO2011157908A8 (fr)	2013-01-17
EP2404600B1 (fr)	2015-05-27
CY1116438T1 (el)	2017-02-08
HRP20150745T1 (hr)	2015-08-14
IL223293A0 (en)	2013-02-03
CR20120609U (es)	2013-02-05
DK2404600T3 (en)	2015-08-31
US20110306598A1 (en)	2011-12-15
WO2011157908A1 (fr)	2011-12-22
GEP20146132B (en)	2014-08-11
ECSP12012337A (es)	2012-12-28
BRPI1102830F1 (pt)	2022-03-29
KR20110136752A (ko)	2011-12-21
TW201206445A (en)	2012-02-16
ME02476B (me)	2017-02-20
CU24161B1 (es)	2016-03-31
AU2011202607B2 (en)	2015-02-12
JP2012001545A (ja)	2012-01-05
SA114360089B1 (ar)	2016-02-03
FR2961105A1 (fr)	2011-12-16
EA201100773A1 (ru)	2011-12-30
ES2582157T3 (es)	2016-09-09
HK1210011A1 (zh)	2016-04-15
FR2961105B1 (fr)	2013-02-08
PL2921168T3 (pl)	2016-10-31
PE20120019A1 (es)	2012-02-11
CY1117724T1 (el)	2017-05-17
HUE027788T2 (en)	2016-10-28
CN104906579A (zh)	2015-09-16
PH12012502315B1 (en)	2020-09-18
CA2743527A1 (fr)	2011-12-15
HRP20160643T1 (hr)	2016-07-01
RS54077B1 (sr)	2015-10-30
GT201200341A (es)	2014-03-14
IL223293A (en)	2017-04-30
EP2404600A1 (fr)	2012-01-11
MA33235B1 (fr)	2012-05-02
CU20120166A7 (es)	2013-04-19
PH12012502315A1 (en)	2013-02-04
ME02163B (me)	2015-10-20
RS54838B1 (sr)	2016-10-31
KR101389879B1 (ko)	2014-04-29

Publication	Publication Date	Title
EP2440209A4 (en)	2013-03-20	COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HEART FAILURE
IL222888A0 (en)	2012-12-31	Anchored cardiac ablation catheter
IL221127A0 (en)	2012-09-24	Devices and systems for treating heart failure
EP2598066B8 (en)	2017-10-18	Generator and combination of a generator and a catheter for providing an electrical pulse
IL220876A0 (en)	2012-09-24	Treatment of cardiac conditions
EP2579938A4 (en)	2014-06-11	ADJUSTABLE MEDICAL ELECTRODE
AP2016009002A0 (en)	2016-01-31	Use of a combination of an inhibitor of the if current of the sinus node and an inhibitor of the angiotensin converting enzyme for the treatment of heart failure
EP2435981A4 (en)	2014-10-15	ROBOT MANAGEMENT OF PATIENT PATTERNS
IL207236A (en)	2015-08-31	Chair helps
DK2405674T3 (da)	2017-01-02	Høreapparat med okklusionsreduktion
GB201313053D0 (en)	2013-09-04	Modular anode assemblies and methods of using the same for electrochemical reduction
GB2498027B (en)	2015-08-26	Power converter
WO2010132347A9 (en)	2011-03-17	Docosahexaenoic acid for the treatment of heart failure
GB201012808D0 (en)	2010-09-15	Implantable electrode
HUE060876T2 (hu)	2023-04-28	Szulkardin alkalmazása atriális fibrilláció kezelésére
GB201103817D0 (en)	2011-04-20	Sealed and bendable catheter
GB0806047D0 (en)	2008-05-14	Treatment of heart failure
BR112012002880A2 (pt)	2016-03-22	desfibrilador cardíaco
FI20095792A0 (fi)	2009-07-15	Ihmissolujen käyttö
EP2558655A4 (en)	2017-06-21	Generator and bidet comprising the same
ZA201005770B (en)	2012-07-25	The treatment of damaged skin
AU2009902224A0 (en)	2009-06-04	The Management of Electro-medical Devices
GB0804320D0 (en)	2008-04-16	Treatment of heart failure
GB0816662D0 (en)	2008-10-22	Treatment of heart failure
HK1174292A (en)	2013-06-07	Methods and devices for treating heart failure